Viewing Study NCT01608594


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2026-01-25 @ 3:19 AM
Study NCT ID: NCT01608594
Status: COMPLETED
Last Update Posted: 2018-08-28
First Post: 2012-05-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma
Sponsor: Diwakar Davar
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords: